A pilot study exploring the reproducibility and suitability for multi-center clinical trials of fMRI bold signal during a monetary incentive delay task and arterial spin labeling with and without prior administration of Risperidone
Completed
- Conditions
- n.v.t.Specific imaging methods
- Registration Number
- NL-OMON46683
- Lead Sponsor
- Millennium Pharmaceuticals, Inc. A Takeda Oncology Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 5
Inclusion Criteria
- healthy male subjects
- 18 to 45 yrs, inclusive, at screening
- BMI: 18.0 to 30.0 kg/m2, inclusive
Exclusion Criteria
Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>fMRI</p><br>
- Secondary Outcome Measures
Name Time Method <p>n.v.t.</p><br>